We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

High magnification micrograph of microglia cells stained with Rio-Hortega's method (silver carbonate). This type is the ramified or resting microglia that appears in normal brain tissue.

Mobilizing Microglia in the Fight Against Alzheimer’s Disease

Cancer cells.

Immunotherapy After Kidney Cancer Surgery Improves Overall Survival

The outline of a person and their brain facing a cannabis leaf and symbolic CBN pill.

Cannabinols Show Neuroprotective Properties in Fruit Flies

Antipsychotic Use in Dementia Linked to Elevated Health Risks

Soil Bacteria Produce Unique Antimicrobial Particles

AI Method Accelerates Drug Discovery for Parkinson’s 10-Fold, Study Finds

News

ProtAb Receives U.S. Patent for Proximab for the treatment of RA and Type-1 Diabetes

The patent covers Proximab’s structure as well as its immune and therapeutic activity against rheumatoid arthritis and Type-1 diabetes.

DxTerity Diagnostics and City of Hope Announce Therapeutics Collaboration

The collaborators will develop therapeutic applications for DxTerity’s proprietary NEAT™ technology.

Maas Biolab SBIR Enters Phase II for Cyclosporin ALS Treatment

Company advance to Phase II of its SBIR grant “Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis.”

Oxford Nanopore Technologies Announces Participation in €12M READNA Project

Consortium to improve DNA analysis technologies launches under EU Seventh Framework Programme.

PharmaEngine Receives Approval of US IND Application for a Phase II Study of PEP02 in Pancreatic Cancer

The phase II study is an open-label, multi-national, optimal 2-stage design to be conducted in the US and Taiwan.

DxS and Amgen Enter into Collaboration to Provide a K-RAS Companion Diagnostic for Vectibix® in the United States

Companies plan to work together to further facilitate the use of Vectibix® in metastatic colorectal cancer patients with wild-type K-RAS status.

Neuralstem Collaborates with Hospital in Taiwan to Develop Additional ALS Stem Cell Clinical Trials

The collaboration aims to advance development of Neuralstem's human spinal cord neural stem cell therapies.

Response Biomedical Corporation Initiates Respiratory Syncytial Virus Infection Clinical Trial

Prospective data is expected to be used to support a submission to FDA for market clearance of the 3M Rapid Detection RSV test for clinical use.

BioTrove and Gene Express to Co-Market Novel Standardised Genetic Profiling Test

BioTrove Inc. and Gene Express, Inc. announced an exclusive co-marketing agreement to test market a standardised genetic profiling test for indicators of lung cancer risk.

Vical Receives Milestone Payment from Merck Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial

Vical announces receipt of a $1.0 million milestone based on Merck's planned initiation of a Phase I clinical trial of pDNA cancer vaccine.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter